CVRx Expects Q4, FY24 Revenues To Rise; Stock Climbs

(RTTNews) - CVRx, Inc. (CVRX), Monday announced preliminary results, expecting a growth of 35 percent and 30 percent in the fourth quarter and full year 2024, respectively.

For the quarter, the medical device company expects revenue of $15.2 million to $15.3 million, and the same for the full year 2024 is estimated to be $51.1 million to $51.2 million.

Looking ahead, the company expects total revenue between $63.0 million and $65.0 million for the fiscal year 2025, and between $14.5 million and $15.0 million for the first quarter of 2025.

Currently, CVRx's stock is trading at $14.69, up 3.71 percent on the Nasdaq.